Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | CA1 | P00915 | 6/20 | 0.50 |
| ▸ | CA2 | P00918 | 6/20 | 0.50 |
| ▸ | NAMPT | P43490 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
| ▸ | CA7 | P43166 | 1/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3180689 | 0.84 | L3MBTL1 (0.61) | L3MBTL1CA1CA2NAMPTGAA | |
| SCHEMBL26148065 | 0.82 | L3MBTL1 (0.53) | L3MBTL1CA1CA2NAMPTGAA | |
| SCHEMBL8138303 | 0.81 | L3MBTL1 (0.52) | L3MBTL1CA1CA2NAMPTGAA | |
| SCHEMBL507480 | 0.81 | L3MBTL1 (0.52) | L3MBTL1CA1CA2NAMPTGAA | |
| SCHEMBL24542517 | 0.79 | L3MBTL1 (0.51) | L3MBTL1CA1CA2NAMPTGAA | |
| SCHEMBL1852791 | 0.79 | EPHX2 (0.58) | L3MBTL1CA1CA2NAMPTGAA | |
| SCHEMBL6376608 | 0.79 | TDP1 (0.51) | L3MBTL1CA1CA2NAMPTGAA | |
| Hydrochloric Acid SCHEMBL23270117 | 0.79 | L3MBTL1 (0.51) | L3MBTL1CA1CA2NAMPTGAA | |
| SCHEMBL5747846 | 0.79 | CTSK (0.51) | L3MBTL1CA1CA2NAMPTGAA | |
| SCHEMBL10165179 | 0.79 | NAMPT (0.56) | L3MBTL1CA1CA2NAMPTGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2176277-B1 | NUCLEOTIDES AND APTAMERS CONTAINING BORONIC ACID GROUPS HAVING BIASED BINDING TO GLYCOSYLATED PROTEINS, AND USES THEREOF | UNIV GEORGIA STATE RES FOUND (US) | 2016-02-24 | — | — | EP | disclosed |
| US-9096856-B2 | Nucleotides and aptamers containing boronic acid groups having biased binding to glycosylated proteins, and uses thereof | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2015-08-04 | — | — | US | disclosed |
| US-20130184160-A1 | NUCLEOTIDES AND APTAMERS CONTAINING BORONIC ACID GROUPS HAVING BIASED BINDING TO GLYCOSYLATED PROTEINS, AND USES THEREOF | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2013-07-18 | — | — | US | disclosed |
| US-20110144187-A1 | APTAMER INHIBITION OF THROMBUS FORMATION | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION | 2011-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130184160-A1 | NUCLEOTIDES AND APTAMERS CONTAINING BORONIC ACID GROUPS HAVING BIASED BINDING TO GLYCOSYLATED PROTEINS, AND USES THEREOF | TENT4A, PABPC4, NUDT21 | L3MBTL1 971/4885CA1 3488/4885CA2 3556/4885 |
| US-20110144187-A1 | APTAMER INHIBITION OF THROMBUS FORMATION | FGB, F13B, GP6 | L3MBTL1 404/4885CA1 2591/4885CA2 2636/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.